Traws Pharma
TRAW
8 hedge funds and large institutions have $2.5M invested in Traws Pharma in 2015 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 2 closing their positions.
11% less funds holding
Funds holding: 9 → 8 (-1)
11% less capital invested
Capital invested by funds: $2.81M → $2.5M (-$314K)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $34K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$143K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Alyeska Investment Group
Chicago,
Illinois
|
-$221K |
| 2 |
Goldman Sachs
New York
|
-$143K |
| 3 |
D.E. Shaw & Co
New York
|
-$64K |
| 4 |
SIM
Spark Investment Management
New York
|
-$34K |
| 5 |
Janney Montgomery Scott
Philadelphia,
Pennsylvania
|
-$28K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
26
Janney Montgomery Scott
Philadelphia,
Pennsylvania
| – | -$28K | – | – |
|
27
Simplex Trading
Chicago,
Illinois
| – | -$1K | – | – |
|
|
SIM
28
Spark Investment Management
New York
| – | -$34K | – | – |
|
TRAW Hedge Fund Activity: Q2 2015 in Review
8 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in Traws Pharma (TRAW) for Q2 2015, worth a combined $2.5M — down 11% from $2.81M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of TRAW and 1 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest buyer was Jacobs Levy Equity Management, opening a new position worth an estimated $143K. The largest seller was Alyeska Investment Group, exiting entirely with an estimated $221K sold.
- 8 institutional investors held Traws Pharma (TRAW) as of Q2 2015, down from 9 in Q1 2015.
- Funds reported $2.5M of Traws Pharma stock for Q2 2015, down 11% quarter-over-quarter.
- 1 fund opened new Traws Pharma positions in Q2 2015 and 2 closed out, a net change of -1 holder.
- The largest Traws Pharma buyer in Q2 2015 was Jacobs Levy Equity Management, an estimated $143K added.
- The largest Traws Pharma seller in Q2 2015 was Alyeska Investment Group, an estimated $221K sold.
Based on aggregated 13F filings for Q2 2015.